⚲
|
Invitae Corp | |
---|---|
Ticker | NVTA |
CIK # | 0001501134 |
CUSIP | 46185L103 |
Sector | Life Sciences |
Industry | Services-Medical Laboratories |
Phone | 4159928173 |
Address | 458 Brannan Street San Francisco, CA 94107 |
Source | [EDGAR] |
Market Cap, 13F ($) |
---|
Business |
---|
This report contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this report other than statements of historical fact, including statements identified by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions, are forward‑looking statements. Forward‑looking statements include, but are not limited to, statements about: -our views regarding the future of genetic testing and its role in mainstream medical practice; -our mission and strategy for our business, products and technology, including our ability to expand our content and develop new content while maintaining attractive pricing, further enhance our genetic testing service and the related user experience, build interest in and demand for our tests and attract potential partners; |
CIK | Filing | 2011 - 2023 |
---|---|---|
[0001501134] | 10-K | |
[0001501134] | 10-Q | |
[0001501134] | 3 | |
[0001501134] | 4 | |
[0001501134] | 8-K | |
[0001501134] | D | |
[0001501134] | SC 13D | |
[0001501134] | SC 13G |